Pride in gastroenterology and hepatology, inspired by the Review on p377.

Pleasurable and problematic receptive anal intercourse and diseases of the colon, rectum and anus

  • Daniel R. Dickstein
  • Collin R. Edwards
  • Deborah C. Marshall
Review Article


  • Focus on liver fibrosis

    Leading experts describe their key advances of the year. Topics covered include: liver transplantation; gut microbiota; ENS; IBD; obesity; CRC.

  • Image shows organs, neurons and microbes in the spotlight

    This Collection covers articles about the pathophysiology and therapeutic implications of Liver Fibrosis.

  • Image of Nature Reviews Gastro twitter logo

    Follow us for news about the journal and the latest updates from the gastroenterology and hepatology field.


series of fatty livers on a yellow background


Fuelled by increasing obesity rates, metabolic dysfunction associated steatotic liver disease (MASLD, formerly known as NAFLD) has emerged as a leading global cause of chronic liver disease in the past few decades. Despite growing prevalence, the factors influencing MASLD development and subsequent progression to metabolic dysfunction associated steatohepatitis (MASH), liver fibrosis, cirrhosis and hepatocellular carcinoma are poorly understood. In this article series, Nature Reviews Gastroenterology & Hepatology explores the epidemiology of MASLD, disease mechanisms and therapeutics, and clinical approaches to diagnosis and management.